Haber Trilix Advisors »

Endo Pharmaceuticals shares owned by Haber Trilix Advisors

Quarter-by-quarter ownership of Endo Pharmaceuticals shares owned by Haber Trilix Advisors from 13F filings

Historical chart of Haber Trilix Advisors investment in Endo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Endo Pharmaceuticals held by Haber Trilix Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Endo Pharmaceuticals by Haber Trilix Advisors

Quarter filed Position value Share count Share price at filing
2013-06-30 $7.0k 180 38.89